Company / Operating Margin
Catalyst Pharmaceuticals Partners, Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
43.8%
FY2025
5-year range
21.8% / 47.5%
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#5 of 136
Health Care
What the data says
Among 136 Health Care companies, Catalyst Pharmaceuticals Partners, Inc. is in the top 4% for operating margin. Improved from 21.8% to 43.8% over the past 2 years.
Based on SEC 10-K filings.
43.8% in FY2025 with a 5-year CAGR of +9.1%. Top quartile in the Health Care sector.
Improved from 21.8% to 43.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -3.8pp
- 5-Year Change
- +9.1pp
- 10-Year Change
- -
Sector benchmark
Top 4% in Health CareTop 4% of 136This company 43.8% Sector average -778.9%
▼
+105.6% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 10.3% year-over-year.
- Currently 822.7pp above the Health Care sector average.
- Peak operating margin was recorded in FY2022.
- Lowest operating margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 43.8% | +10.3% |
| FY2024 | 39.7% | +82.0% |
| FY2023 | 21.8% | -54.1% |
| FY2022 | 47.5% | +27.8% |
| FY2021 | 37.2% | +7.2% |
| FY2020 | 34.7% | +11.5% |
| FY2019 | 31.1% | +100.4% |
| FY2018 | -7059.0% | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026